NCT06411587

Brief Summary

The goal of this observational study is to understand the impact of spasticity on muscle changes and functional performance in stroke patients with lower limb spasticity in comparison to non-stroke individuals. The main questions it aims to answer are:

  • How does spasticity affect muscle changes and lower limb functional performance in stroke patients?
  • How do structural and textural parameters in ultrasound images differ between spastic stroke patients and non-stroke individuals? Participants will undergo ultrasound evaluation of their leg muscles to measure structural and textural parameters. They will also take part in functional assessments to assess their performance in activities related to lower limb mobility. Researchers will compare the structural and textural ultrasound parameters between stroke patients and non-stroke individuals to determine any notable differences. The study aims to identify the relationship between muscle changes, spasticity, and functional performance in stroke patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Feb 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 27, 2024

Completed
10 days until next milestone

First Submitted

Initial submission to the registry

March 8, 2024

Completed
2 months until next milestone

First Posted

Study publicly available on registry

May 13, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
Last Updated

May 22, 2025

Status Verified

April 1, 2025

Enrollment Period

9 months

First QC Date

March 8, 2024

Last Update Submit

May 21, 2025

Conditions

Keywords

StrokeUltrasound imagingSpasticity, muscleFunction

Outcome Measures

Primary Outcomes (1)

  • Muscle thickness

    It is the distance between the superficial and deep layer of the fascia of the medial gastrocnemius. It is considered one of the 3 muscular architecture parameters that will be measured using ultrasound images collected with the Butterfly iQ+ portable device by Butterfly Network, Inc., a company located in the United Kingdom. The device is connected to a tablet from which the images are visualized and captured. For more information about the device, you can visit the following link: www.butterflynetwork.com/int/es-es/individual

    Through study completion, an average of 1 year

Secondary Outcomes (8)

  • Fascicle length

    Through study completion, an average of 1 year

  • Pennation angle

    Through study completion, an average of 1 year

  • Concurrence matrices

    Through study completion, an average of 1 year

  • Degree of spasticity

    Through study completion, an average of 1 year

  • Functional capacity

    Through study completion, an average of 1 year

  • +3 more secondary outcomes

Study Arms (2)

Patients with stroke

Patients with a chronic stroke and spasticity in the ankle flexors muscles.

Diagnostic Test: Ultrasound imaging and functional assessment

Patients without stroke

Patients without stroke were matched with those with stroke based on age and sex.

Diagnostic Test: Ultrasound imaging and functional assessment

Interventions

Participants in this study will undergo two types of assessments: capturing muscle images using ultrasound and evaluating their function through clinical scales.

Patients with strokePatients without stroke

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Stroke group: patients diagnosed with ischemic or hemorrhagic stroke who follow the selection criteria. Non-stroke group: patients without a diagnosis of stroke matching with each member of the stroke group.

You may qualify if:

  • Age over 18 years
  • Present spasticity in the plantar flexor muscles of the ankle as a result of a first unilateral ischemic or hemorrhagic stroke (excluding subarachnoid hemorrhage, as it is not truly a stroke) diagnosed by computed tomography or magnetic resonance imaging.
  • Have more than 6 months of evolution since the onset of the cerebrovascular accident (chronic stroke).
  • Degree of spasticity on the Modified Ashworth Scale (MAS): 1, 1+, 2, or 3.
  • Be able to walk independently with or without assistance.

You may not qualify if:

  • Other musculoskeletal or neurological disorders affecting the lower limb (bilateral stroke, peripheral neuropathy, peripheral nerve injury, myopathy, severe osteoarthritis, recent muscle injury, recent bone fracture, joint replacement, fixed contractures involving the affected leg, bone deformities of the lower limbs).
  • Other neurological pathologies (e.g., ataxia or dystonia).
  • Surgical intervention in the lower limb.
  • Cognitive impairments that hinder study measurements.
  • Other medical conditions that may interfere with data interpretation.
  • Group of non-stroke patients
  • Age over 18 years
  • Be able to walk independently with or without assistance
  • Previous diagnosis of stroke.
  • Presence of spasticity in any part of the body.
  • Other musculoskeletal or neurological disorders affecting the lower limb (bilateral stroke, peripheral neuropathy, peripheral nerve injury, myopathy, severe osteoarthritis, recent muscle injury, recent bone fracture, joint replacement, fixed contractures involving the affected leg, bone deformities of the lower limbs).
  • Other neurological pathologies (e.g., ataxia or dystonia).
  • Surgical intervention in the lower limb.
  • Cognitive impairments that hinder study measurements.
  • Other medical conditions that may interfere with data interpretation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidad de Zaragoza

Zaragoza, Aragon, 50009, Spain

Location

MeSH Terms

Conditions

StrokeMuscle Spasticity

Interventions

Ultrasonography

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesMuscular DiseasesMusculoskeletal DiseasesMuscle HypertoniaNeuromuscular ManifestationsNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosis

Study Officials

  • Pablo Herrero Gallego, Physical Therapist

    Universidad de Zaragoza

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor and PhD

Study Record Dates

First Submitted

March 8, 2024

First Posted

May 13, 2024

Study Start

February 27, 2024

Primary Completion

December 1, 2024

Study Completion

December 30, 2024

Last Updated

May 22, 2025

Record last verified: 2025-04

Locations